Clorox (CLX) is a publicly traded Consumer Defensive sector company. As of May 20, 2026, CLX trades at $94.57 with a market cap of $11.22B and a P/E ratio of 15.38. CLX moved +1.70% today. Year to date, CLX is -6.93%; over the trailing twelve months it is -30.44%. Its 52-week range spans $84.70 to $171.37. Analyst consensus is neutral with an average price target of $100.23. Rallies surfaces CLX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Which politicians traded CLX stock?
Recent politician trading activity in CLX includes disclosures from Gilbert Cisneros, Lisa McClain, Jefferson Shreve, Tommy Tuberville, and Tommy Tuberville. Rallies tracks purchase and sale disclosures, transaction dates, owners, reported amounts, and post-trade performance context.
CLX Key Metrics
Key financial metrics for CLX
Metric
Value
Price
$94.57
Market Cap
$11.22B
P/E Ratio
15.38
EPS
$6.14
Dividend Yield
1.24%
52-Week High
$171.37
52-Week Low
$84.70
Volume
2.04M
Avg Volume
0
Revenue (TTM)
$6.76B
Net Income
$770.00M
Gross Margin
44.19%
Congressional Trades in CLX
Gilbert Cisneros sale CLX on Nov 12, 2025 (amount: $15.00K).
Lisa McClain purchase CLX on Jun 24, 2025 (amount: $15.00K) for Spouse.
Jefferson Shreve sale CLX on Apr 11, 2025 (amount: $50.00K).
Tommy Tuberville purchase CLX on Apr 29, 2024 (amount: $15.00K) for Joint.
Tommy Tuberville sale (partial) CLX on Oct 31, 2023 (amount: $250.00K) for Joint.
Recent politician trading activity in CLX includes disclosures from Gilbert Cisneros, Lisa McClain, Jefferson Shreve, Tommy Tuberville, and Tommy Tuberville. Rallies tracks purchase and sale disclosures, transaction dates, owners, reported amounts, and post-trade performance context.
Does Rallies track congressional trades in CLX?
Yes. Rallies tracks politician and congressional stock disclosures for CLX, including reported purchases, sales, dates, owners, and trade amounts when available.
Is CLX research on Rallies investment advice?
No. Rallies provides research, data, and educational context for CLX. It does not provide personalized investment advice.